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 ABSTRACT--We investigated whether or not proliferation of adult rat 
hepatocytes induced by platelet-derived growth factor (PDGF) is affected by 
 α1-adrenoceptor agonists such as phenylephrine during the early and late 
phases of primary culture. Adult rat hepatocytes underwent significant 
DNA synthesis after culture with 10 ng/ml PDGF for 2 hr at a low cell 
density (3.3 x 104 cells/cm2). Under these culture conditions, the number of 
nuclei increased significantly during the 3.5 hr culture period. Hepatocyte 
DNA synthesis and proliferation induced by 10 ng/ml PDGF decreased 
slightly as a result of increasing the initial plating density. An 
α1-adrenoceptor agonist, phenylephrine (10-6 - 10-5 M), alone did not affect 
hepatocyte DNA synthesis and proliferation, but the markedly potentiated 
PDGF-induced hepatocyte DNA synthesis and proliferation. The 
phenylephrine effect was mimicked by phorbol myristate acetate (10-7 M), 
but not by ionomycin (10-5 M). The mitogenic effects of PDGF were almost 
completely blocked by treating hepatocytes with genistein (5 x 10-6 M), 
U-73122 (3 x 10-6 M), sphingosine (10-5 M), wortmannin (10-7 M), and 
rapamycin (10 ng/ml). These results demonstrate that PDGF can induce the 
proliferation of adult rat hepatocytes rapidly in primary culture, regardless 
of the initial plating density. The present results also suggest that following 
stimulation with PDGF, activation of tyrosine kinase, phospholipase C, 
phosphatidylinositol 3-kinase, protein kinase C (PKC) and p70 ribosomal 
protein S6 kinase is essential for proliferation of adult rat hepatocytes. The 
co-mitogenic effects of phenylephrine may involve PKC activation. 
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 INTRODUCTION  
The majority of research on the mechanisms associated with hepatic 
growth has used partially hepatectomized animals in vivo (1). Studying 
hepatocytes in primary culture in conjunction with current in vivo methods 
would provide a valuable tool for increasing our understanding of 
hepatocyte proliferation, because the influences of stimulatory and 
inhibitory factors in vivo can be isolated in the culture model. Thus, the 
growth conditions that may play a role in hepatocyte replication in vivo may 
be clarified in vitro. For example, hepatic parenchymal cells that are 
cultured in a defined medium for 24 hr and 48 hr undergo DNA synthesis 
and proliferation in the presence of a variety of growth factors, including 
epidermal growth factor (EGF), insulin and hepatocyte growth factor (HGF) 
(2-4). 
 In contrast, we have reported previously that EGF and insulin alone can 
rapidly stimulate hepatocyte DNA synthesis and proliferation during 
short-term cultures (i.e. approx. 3-4 hr) (5, 6). The density dependency of 
hepatocyte proliferation is regulated differently between these growth 
factors. Hepatocyte DNA synthesis and proliferation induced by EGF are 
strictly dependent on the initial plating density, unlike insulin induction, 
which appears to be independent of the initial plating density. Furthermore, 
EGF- or insulin-stimulated hepatocyte DNA synthesis and proliferation 
appear to be potentiated by β-adrenoceptor agonists and other 
cAMP-elevating agents. 
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  Similarly, platelet-derived growth factor (PDGF) is a potent stimulator of 
the proliferation of connective-tissue cell such as fibroblasts and smooth 
muscle cells (7, 8), and may play a role in the liver regeneration process (1). 
Recent studies have begun to demonstrate the signal transduction pathway 
activated in response to PDGF in some cell types (9,10). The receptor for 
PDGF, like the receptor for EGF, insulin and HGF, contains intrinsic 
tyrosine kinase activity. The mitogenic effects of PDGF are reportedly 
mediated through the activation of tyrosine kinase-linked receptors. 
However, little is known about which of the signals originating in the 
plasma membrane are involved in the induction of hepatocyte DNA 
synthesis and proliferation by PDGF. Thus, the present study investigated 
the direct action of PDGF on DNA synthesis and replication of adult rat 
hepatocytes in primary culture in vitro. It also investigated the effects of 
α1-adrenoceptor agonist on PDGF-induced DNA synthesis and proliferation 
in adult rat hepatocytes to clarify the relationship between PDGF action 
and α1-adrenoceptor responses, since there are indications that hepatocyte 
DNA synthesis and proliferation are modified by α1-adrenoceptor 
receptor-mediated responses (11-15) in the presence of HGF. Finally, the 
cell signaling systems involved in PDGF responsiveness in primary cultures 
of adult rat hepatocytes were investigated by pharmacological approaches. 
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 MATERIALS AND METHODS 
Hepatocyte isolation and culture 
 Male Wistar rats (weight 200-250 g) were obtained from Saitama 
Experimental Co. (Saitama). The rats were anesthetized by intraperitoneal 
injection of sodium pentobarbital (45 mg/kg). Two-step in situ collagenase 
perfusion was performed to facilitate disaggregation of the adult rat liver as 
described previously (16, 17). Briefly, the liver was first washed via the 
portal vein with a calcium-free 10 mM HEPES buffer (pH 7.4) at 37℃ and a 
flow rate of 30 ml/min for 10 min. The second step was performed with the 
same buffer containing 0.025% collagenase and 0.075% CaCl2 at flow rate of 
30 ml/min for 10 min. The cells were dispersed in Ca2+-free Hanks’ solution 
containing kanamycin (48 μg/ml). The cells were then washed three times by 
slow centrifugation (120g) for 1 min in order to remove cell debris, damaged 
cells and non-parenchymal cells. The viability of hepatocytes always 
exceeded 94%, as determined by the trypan blue exclusion test. Unless 
otherwise indicated, isolated hepatocytes were plated onto collagen-coated 
plastic culture dishes (Sumitomo Bakelite Co., Tokyo) at a density of 3.3 x 
104 cells/cm2 in Williams’ medium E containing 5% bovine calf serum, 10-10 
M dexamethasone for 3 hr in 5% CO2 in air. The medium was then changed, 
and the cells were cultured in serum-free Williams’ medium E containing 
various concentrations of PDGF with or without a β-adrenoceptor agonist, 
cAMP-elevating agents, an α1-adrenoceptor agonist, and/or specific 
inhibitors of signal transducers.  
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 Measurement of DNA synthesis 
 Hepatocyte DNA synthesis was assessed by measuring the incorporation of 
[3H]thymidine into acid-precipitable materials (18). Briefly, after an initial 
attachment period of 3 hr, hepatocytes were washed twice with serum-free 
Williams’ medium E and cultured in a medium containing 10 ng/ml PDGF 
for a further 4 hr and 21 hr. The cells were pulsed at 2 hr and 19 hr 
post-PDGF stimulation for 2 hr with [3H]thymidine (1.0 μCi/well). 
Incorporation into DNA was then determined as described previously (5). 
Hepatocyte protein content was measured by a modified Lowry procedure 
with bovine serum albumin as a standard (19). 
 
Counting nuclei 
 The number of nuclei was counted instead of the cell number according to 
the previously described procedure of Nakamura et al. with minor 
modifications (4). Briefly, the primary cultured hepatocytes were washed 
twice with 2 ml of Dulbecco’s phosphate-buffered saline (pH 7.4). The cells 
were then lysed by incubation with 0.25 ml of 0.1 M citric acid containing 
0.1 % Triton x-100 for 30 min at 37℃. An equal volume of the nucleus 
suspension was mixed with 0.3% trypan blue in Dulbecco’s 
phosphate-buffered saline (pH 7.4) and the number of nuclei was counted in 
a hemocytometer (5). This procedure was performed because the 
hepatocytes had firmly attached to the collagen-coated plates and were not 
dispersed by EDTA-trypsin treatment. 
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 Materials 
 The following reagents were obtained from Sigma Chemical Co. (St. Louis, 
MO, USA): forskolin, dibutyryl cAMP (db-cAMP), genistein, aphidicolin, 
metaproterenol hemisulfate, phenylephrine hydrochloride, prazosin 
hydrochloride, yohimbine hydrochloride, D-sphingosine, ionomycin calcium 
salt, UK14304 (5-bromo-6-[2-imidazolin-2-ylamino]-quinoxaline), 
wortmannin, rapamycin, angiotensin II, arginine vasopressin, and 
dexamethasone. Platelet-derived growth factor-BB (human recombinant) 
was obtained from R & D Systems (Mineapolis, MN, USA). Phorbol 
12-myristate 13-acetate (PMA) and suramin hexasodium salt was 
purchased from Research Biochemicals International (Natick, MA, USA). 
U-73122 (1-[6-[[17β-3-methoxyestra-1, 3, 5 (10)-triene-17-yl] amino] 
hexyl]-1H pyrrol-2, 5-dione) and U-73343 (1- [6-[[17β-3-methoxyestra-1, 3, 5 
(10)-triene-17-yl] amino] hexyl]-2, 5-pyrrolidine-dione) were obtained from 
BIOMOL Research Laboratories, Inc. (Plymouth Meeting, PA, USA). 
Williams’ medium E and new born calf serum were purchased from Flow 
Laboratories (Irvine, Scotland). Collagenase (type II) was obtained from 
Worthington Biochemical Co., (Freehold, NJ, USA). [Methyl-3H]thymidine 
(20 Ci/mmol) was obtained from DuPont-New England Nuclear (Boston, MA, 
USA). All reagents were of analytical grade. 
 
Statistical analysis 
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  Data are expressed as mean ± S.E.M. Data were analyzed by the unpaired 
Student’s t-test. P values less than 0.05 were regarded as statistically 
significant. 
 
RESULTS 
Time course of stimulation of hepatocyte DNA synthesis and 
proliferation by PDGF with or without phenylephrine 
 Isolated adult rat hepatocytes were treated using PDGF with or without 
phenylephrine for various culture periods, and DNA synthesis was 
measured by [3H]thymidine incorporation at a low cell density (3.3 x 104 
cells/cm2). DNA synthesis was induced in hepatocytes after only 2 h and 
reached a maximum 6.5 - 7.0 hr after the addition of PDGF (10 ng/ml). DNA 
synthesis then became reduced by 21 hr after addition (Fig. 1). A significant 
increase in the number of nuclei (proliferation) induced by PDGF (10 ng/ml) 
was observed approximately 3.5 hr after PDGF addition, reached a peak at 
4 hr and was sustained for a further 21 hr. Therefore, the detected increase 
in the number of nuclei could be due to an increase in [3H]thymidine 
incorporation. Thus, both hepatocyte DNA synthesis and proliferation 
induced by PDGF (10 ng/ml) were found to be potentiated in the presence of 
an α1-adrenoceptor agonist, phenylephrine (10-6 M). 
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 Dose-dependent effects of PDGF on hepatocyte DNA synthesis and 
proliferation 
 Figure 2 shows the dose-dependent effect of PDGF on DNA synthesis in 
hepatocytes cultured for 4 hr at a low density (3.3 x 104 cells/cm2). Peak 
stimulation of hepatocyte DNA synthesis occurred at 10 ng/ml and showed 
an EC50 of 2.5 ± 0.3 ng/ml (n=3). PDGF increased the number of nuclei by 
approximately 1.2fold with a maximal concentration of 10 ng/ml (EC50:3.5 ± 
0.3 ng/ml, n=3). 
 
Influence of cell density on PDGF-stimulated hepatocyte DNA 
synthesis and proliferation with or without phenylephrine 
 To determine if the proliferative effect of PDGF is affected by the initial 
plating density, we investigated the density-dependency of hepatocyte DNA 
synthesis and proliferation induced by 10 ng/ml PDGF with or without 
phenylephrine (10-6 M). Figure 3 shows that hepatocyte DNA synthesis 
induced by PDGF (10 ng/ml) was not influenced significantly by the initial 
plating density. However, phenylephrine-stimulated hepatocyte DNA 
synthesis in the presence of PDGF was significantly inhibited at a higher 
cell density. As shown in Fig. 4, the increase in the number of nuclei 
induced by 10 ng/ml PDGF reached a plateau at a cell density of 3.3 x 104 
cells/cm2. This increase occurred during the early phase of culture. 
Hepatocytes cultured without 10 ng/ml PDGF for 4 hr did not show any 
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 significant effect on hepatocyte DNA synthesis or proliferation at various 
cell densities (Figs. 3 and 4, respectively). 
 
Dose-dependent effects of phenylephrine on PDGF-stimulated 
hepatocyte DNA synthesis and proliferation during early phase of 
primary culture 
 To test the influence of the α1-adrenoceptor-mediated mechanism on PDGF 
activity, we examined the dose-dependent effects of phenylephrine on 
PDGF-stimulated DNA synthesis and proliferation at a low density during 
the early phase of culture (Fig. 5). Phenylephrine alone had almost no effect 
on hepatocyte DNA synthesis and proliferation in the range of 10-8 -10-5 M 
(data not shown). In contrast, the ability of PDGF (10 ng/ml) to induce 
hepatocyte DNA synthesis and proliferation was significantly potentiated by 
the addition of phenylephrine, with maximal potentiation occurring at a 
concentration of 10-6 M (EC50 for DNA synthesis: 0.19 ± 0.02 μM, n=3; EC50 
for nucleus number: 0.3 ± 0.03 μM, n=3). Phenylephrine potentiation was 
dose dependent up to approximately 10-6 M. 
 
Effects of suramin, specific α1- and α2-adrenoceptor antagonists on 
phenylephrine-stimulated hepatocyte DNA synthesis and 
proliferation in the presence of PDGF 
 To confirm α1-adrenoceptor receptor-mediation of 
phenylephrine-stimulated hepatocyte DNA synthesis and proliferation in 
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 the presence of 10 ng/ml PDGF, we examined the effects of a specific α1- 
adrenoceptor antagonist, prazosin, and a specific α2- adrenoceptor 
antagonist, yohimbine, on the potentiation of the PDGF effects induced by 
phenylephrine. As summarized in Table 1, suramin (10-5 M), which is known 
to inhibit PDGF action at the receptor sites (20), significantly blocked 
PDGF-stimulated hepatocyte DNA synthesis and proliferation in the 
absence or presence of phenylephrine. Prazosin (10-6 M) completely inhibited 
the phenylephrine effects, whereas yohimbine (10-6 M) did not affect 
hepatocyte DNA synthesis or proliferation during the early and late phases 
of primary culture. Suramin, prazosin and yohimbine alone had no direct 
effects on PDGF-stimulated hepatocyte DNA synthesis and proliferation 
(data not shown). UK-14304 (10-6 M), a specific α2-adrenoceptor agonist (21), 
did not inhibit phenylephrine-stimulated hepatocyte DNA synthesis and 
proliferation in the presence of PDGF (10 ng/ml). A β2-adrenoceptor agonist, 
metaproterenol, alone had almost no effect on the PDGF-stimulated 
hepatocyte DNA synthesis and proliferation in the range of 10-7 -10-5 M. In 
addition, forskolin (10-6 M) and db-cAMP (10-5 M) alone did not significantly 
affect hepatocyte DNA synthesis and proliferation in the presence of 10 
ng/ml PDGF (data not shown). 
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 Effects of U-73122, sphingosine, PMA and ionomycin on 
phenylephrine- or phorbol ester-stimulated hepatocyte DNA 
synthesis and proliferation in the presence of PDGF 
 We investigated the possible pharmacological role of phospholipase C 
(PLC) and its intracellular second messengers (e.g., 1,2-diacylglycerol (DG) 
and calcium ion) on PDGF-induced hepatocyte DNA synthesis and 
proliferation during the early and late phases of culture. As summarized in 
Table 2, the PLC inhibitor, U-73122 (3 x 10-6 M), attenuated PDGF action on 
hepatocyte DNA synthesis during the 4 hr of culture, but increased the 
response during the 21 hr of culture. U-73343 (10-5 M), a close structural 
analog of U-73122, did not affect PDGF-induced hepatocyte DNA synthesis 
and proliferation during the early and late phases of culture. The specific 
protein kinase C (PKC) inhibitor, sphingosine (10-6 M) also inhibited 
PDGF-induced hepatocyte DNA synthesis during the early phase of culture, 
but increased the response during the late phase of culture. To further 
investigate the possible involvement of DG, the hepatocytes were treated 
with a synthetic analogue, PMA (10-7 M), for 4 hr and 21 hr. Although PMA 
(10-7 M) alone did not significantly affect hepatocyte DNA synthesis and 
proliferation (data not shown), PMA potentiated PDGF-stimulated 
hepatocyte DNA synthesis during the early phase of culture, but the PMA 
effects were reduced during the late phase of culture. The PMA effects were 
significantly blocked by sphingosine (10-6 M), but not by U-73122 (3 x 10-6 M). 
U-73343 did not affect either PMA-induced hepatocyte DNA synthesis or 
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 proliferation up to 10-5 M, as expected. Similarly, to determine the possible 
involvement of intracellular calcium mobilization in hepatocyte DNA 
synthesis and proliferation, cells were cultured with 10-5 M ionomycin for 4 
hr and 21 hr. No changes in the PMA-stimulated hepatocyte DNA synthesis 
and proliferation were observed with ionomycin. Similarly, other calcium 
mobilizing agents such as angiotensin II and arginine vasopressin (10-8 -10-6 
M) did not affect hepatocyte DNA synthesis and proliferation induced by 10 
ng/ml PDGF (data not shown). The results demonstrate that the 
phenylephrine effects were largely mimicked by PMA, but not by ionomycin. 
 
Effect of specific inhibitors of signal-transducing enzymes on 
hepatocyte DNA synthesis and proliferation induced by PDGF with 
or without phenylephrine 
 Next, we investigated whether or not the mitogenic responses of 
hepatocytes to PDGF alone and PDGF with phenylephrine were mediated 
by signal transducers such as receptor tyrosine kinase, phosphatidylinositol 
3-kinase (PI(3)K), and ribosomal protein p70 S6 kinase (p70 S6K). To 
determine whether or not PDGF-stimulated DNA synthesis and 
proliferation require receptor tyrosine kinase activity, hepatocytes were 
treated with PDGF (10 ng/ml) in the presence or absence of a specific 
tyrosine kinase inhibitor, genistein (22), for 4 hr and 21 hr. As summarized 
in Table 3, genistein (5 x 10-6 M) almost completely blocked PDGF-induced 
stimulation of hepatocyte DNA synthesis and proliferation. The 
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 co-mitogenic effect of phenylephrine in the presence of PDGF was 
significantly inhibited by genistein (5 x 10-6 M) during the early and late 
phases of culture. Treatment of hepatocytes with a specific PI(3)K inhibitor, 
wortmannin (10-7 M) (23-25), also completely inhibited PDGF-induced 
stimulation of hepatocyte DNA synthesis and proliferation. Furthermore, 
the co-mitogenic effect of phenylephrine in the presence of PDGF was 
blocked by wortmannin (10-7 M). Table 3 also shows that the 
immunosuppressant rapamycin (10 ng/ml) (26-28) almost completely 
attenuated both the mitogenic effects of PDGF and co-mitogenic effect of 
phenylephrine on hepatocyte DNA synthesis and proliferation during the 
early and late phases of primary culture. 
 
DISCUSSION 
 As shown in Fig.1, we found for the first time that PDGF alone stimulated 
hepatocytes DNA synthesis and proliferation after a lag of approximately 
3-4 hr in primary culture. Similarly, we found that stimulation of 
hepatocytes with PDGF (10 ng/ml) markedly increased hepatocyte DNA 
synthesis and proliferation, particularly when PDGF was added in 
combination with an α1-adrenoceptor agonist such as phenylephrine (Fig.1). 
Since phenylephrine alone did not stimulate hepatocyle DNA synthesis and 
proliferation, the co-mitogenic effects of phenylephrine are likely to be, at 
least in part, explained by interaction with PDGF signaling mechanisms. 
Possible mechanisms for this phenomenon will be discussed later. Figure 1 
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 also showed that based on the similarities with the case of insulin (6), the 
ability of PDGF to induce hepatocyle DNA synthesis and proliferation does 
not appear to be strictly dependent on the initial plating density in the 
absence of phenylephrine (Figs. 3 and 4). The density-independent 
mechanisms of hepatocyte DNA synthesis and proliferation are probably 
due to production of stimulatory autocrine factor(s) and/or reduced 
production of inhibitory autocrine factor(s) by the hepatocytes in primary 
culture (4). Alternatively, it may be a loss of regulation due to cell-cell 
contact (29-31). However, further studies are required to confirm this 
hypothesis.  
PDGF reportedly acts through tyrosine kinase receptors that 
phosphorylate and activate phospholipase C (PLC-γ), which leads to 
enhanced DG and inositol 1,4,5-trisphosphate (IP3) production (32). 
Phenylephrine is also known to exert its action through the stimulation of 
phospholipase C (PLC-β) via Gq-protein. PLC-β catalyzes the hydrolysis of 
phosphatidylinositol 4,5-bisphosphate (PIP2) to IP3 and DG. Generation of 
IP3 leads to mobilization of calcium ions from intracellular stores, whereas 
DG activates different isozymes of the PKC family (32). Therefore, using two 
mechanistically distinct inhibitors of signal transducers, U73122 (an 
inhibitor of PLC) and sphingosine (an inhibitor of PKC), the mechanisms 
leading to PDGF stimulation of hepatocyte DNA synthesis and proliferation 
were investigated (33-35). As summarized in Table 2, U73122 (3 x 10-6 M) 
attenuated the PDGF effect, but not PMA (i.e., cell-permeable synthetic 
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 analogue of DG) effects on hepatocyle DNA synthesis during the early phase 
of culture. The results suggest that PKC is a downstream signal 
transduction element of PLC. Furthermore, both PLC and PKC appeal to 
play an important role in the PDCF regulation of hepatocyte DNA synthesis 
and proliferation. A point of convergence of these two signaling pathways 
may be at the level of PKC.  
As shown in Fig .1, DNA synthesis became reduced significantly by 21 hr 
after the addition of PDGF in the absence or presence of phenylephrine. The 
mechanism underlying the reduction of hepatocyte DNA synthesis may be 
due to desensitization (or down-regulation) of PKC activity, since this 
reduction is significantly reversed by the simultaneous addition of the PKC 
inhibitor sphingosine (10-5 M, Table 2). Such agonist-induced desensitization 
of PKC during long-term culture has been well-documented (36, 37). The 
sensitivity of PDGF desensitization compared with that of insulin or EGF 
response may be an unique regulatory device to reduce PDGF action in the 
absence or presence of α1-adrenoceptor agonists.  
Considering another pathway, if the phenylephrine effects in the presence 
of PDGF are mediated through calcium ions, phenylephrine can be replaced 
by the calcium ionophore, ionomycin (38). However, calcium ions do not 
appear to be involved in the phenylephrine effects, since no changes in 
hepatocyle DNA synthesis and proliferation were observed upon the 
addition of 10-5 M ionomycin when the cells were cultured with 10-5 M 
ionomycin for 4 and 21 hr (Table 2). In addition, this notion is supported by 
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 the results showing that other calcium-mobilizing agents such as 
angiotensin II and arginine vasopressin (10-8 - l0-6 M) did not affect 
hepatocyte DNA synthesis and proliferation induced by 10 ng/ml PDGF 
(data not shown).  
Tyrosine kinase receptors, such as EGF, HGF and PDGF, are known to 
generate IP3 and DG by interacting directly with PLC-γ to stimulate 
hepatocyte growth and proliferation (9, 39-42). Therefore, we investigated 
further the possible signal transduction mechanisms that lead to activation 
of hepatocyte DNA synthesis and proliferation induced by PDGF in primary 
cultures of adult rat hepatocytes (Table 3). The addition of 5 x 10-6 M 
genistein (22) to hepatocyte cultures to inhibit tyrosine kinase results in the 
complete attenuation of PDGF-induced hepatocyte DNA synthesis and 
proliferation, suggesting that the mitogenic effects of this growth factor are 
mediated through tyrosine kinase activation. Hepatocyte DNA synthesis 
and proliferation induced by PDGF was almost completely blocked by 
specific inhibitors of signal transducers such as the specific PI(3)K inhibitor 
wortmannin (10-7 M) and the p70 S6K inhibitor rapamycin (10 ng/ml). 
Consistent with these findings, Valius and Kazlauskas observed that the 
activation of PLC-γ and PI(3)K is sufficient to trigger hepatocyte DNA 
synthesis and proliferation in the human hepatoma cell line Hep G2 (43). 
Furthermore, although there are data correlating increased cellular 
proliferation with the activation of P70S6K (26-28), the precise signal 
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 transduction mechanism to explain all these events is not completely 
defined. Such investigations are now under way in our laboratory.  
In conclusion, our results demonstrate for the first time that PDGF can 
rapidly induce DNA synthesis and proliferation of adult rat hepatocytes in 
primary culture. This induction has been found to be independent of the 
initial plating density. The mitogenic effects of PDGF were markedly 
potentiated by an α1-adrenoceptor agonist, phenylephrine, which may be 
mainly mediated through PKC. The present results also suggest that 
following stimulation with PDGF, activation of tyrosine kinase, PLC. PI(3)K, 
PKC and P70 S6K is essential for hepatocyte DNA synthesis and 
proliferation. Taken together, it can be speculated that 
α1-adrenoeeptor-mediated action plays a positive role in the regulation of 
normal liver growth and liver regeneration induced by PDGF in vivo.  
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 FIGURE LEGENDS 
 
Fig. 1. Time course of associated with stimulation of hepatocyte DNA 
synthesis and proliferation by PDGF with or without phenylephrine. 
Hepatocytes (3.3 x 104 cells/cm2) were cultured with or without 
phenylephrine (10-6 M) in presence of PDGF (10 ng/ml) for various lengths of 
time. PDGF and/or phenylephrine were added at the time of medium change 
as indicated by the arrow. Data are expressed as mean ± S.E. of three 
separate experiments. *P< 0.05, **P< 0.01, compared with the control 
(values just before PDGF addition). 
 
Fig. 2.  Dose-dependent effect of PDGF on hepatocyte DNA synthesis and 
proliferation. Hepatocytes (3.3 x 104 cells/cm2) were cultured with various 
concentrations of PDGF for 4 hr. Data are expressed as mean ± S.E. of three 
separate experiments. 
  
Fig. 3.  Influence of cell density on PDGF-stimulated hepatocyte DNA 
synthesis with or without phenylephrine. Hepatocytes were cultured with 
PDGF (10 ng/ml) in the presence or absence of phenylephrine (10-6 M) at 
various plating densities for 4 hr. Data are expressed as mean ± S.E. of 
three separate experiments. *P< 0.05, **P< 0.01, ***P< 0.001 compared 
with the respective control. 
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 Fig. 4.  Influence of cell density on PDGF-stimulated hepatocyte 
proliferation with or without phenylephrine. Hepatocytes were cultured 
with PDGF (10 ng/ml) at various plating densities for 4 hr. Data are 
expressed as mean ± S.E. of three separate experiments. *P< 0.05, **P< 0.01, 
compared with respective control. 
 
Fig. 5.  Dose-dependent effects of phenylephrine on PDGF-stimulated 
hepatocyte DNA synthesis and proliferation at early phase of primary 
culture. Hepatocytes (3.3 x 104 cells/cm2) were cultured with or without 
various concentrations of phenylephrine (10-6 M) in the presence of PDGF 
(10 ng/ml) for various times. Data are expressed as mean ± S.E. of three 
separate experiments. *P< 0.05, compared with the control (values with 
PDGF addition). 
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Table 1.  Effects of suramin, specific α1- and α2-adrenoceptor antagonists on
phenylephrine-stimulated hepatocyte DNA synthesis and proliferation in the presence of
PDGF 
Treatment          DNA synthesis      Number of nuclei 
(dpm/mg protein/h x 10-3)       (% of control) 
           Culture time (hr)      Culture time (hr)  
       4      21      4     21 
Control 0.435±0.212 0.596±0.448 100.0±2.4 99.9±3.7 
PDGF 5.030±0.307b 2.951±0.569a 119.0±3.2b 124.6±3.0b 
+phenylephrine 10.404±0.921b, d  3.429±0.889a 143.9±3.4b, d 149.9±3.0b, d 
+suramin          1.267±0.322d 2.007±0.633 100.9±2.6c 103.3±3.7c 
+phenylephrine+suramin 1.933±1.006c 1.064±0.923 103.1±3.5c 105.3±3.2c 
+prazosin 4.952±0.400b 2.807±1.005 121.0±3.0b 124.3±3.8a 
+phenylephrine+prazosin 4.854±1.007a 2.918±0.829 123.1±3.0b 128.5±5.2a 
+yohimbine  5.429±1.020b 2.993±0.758 120.6±5.1a 129.0±4.4b 
+phenylephrine+yohimbine 10.812±0.682b, d 3.884±0.834a 145.6±2.8b, d 149.8±4.4b, d 
+UK-14304  4.806±0.663b 2.932±0.668a 120.4±4.4a 124.8±5.2a 
+phenylephrine+UK-14304 10.317±0.832b, d 3.863±0.739a 142.6±2.8b, d 145.8±3.4b, d 
 
Hepatocytes were plated at a density of 3.3 x 104 cells/cm2 and cultured as described in legend
for Fig. 1. Specific α1- and α2-adrenergic antagonists, phenylephrine and cAMP-elevating
agents were added with 10 ng/ml PDGF immediately after medium change and cells were
cultured for a further 4 hr and 21 hr.  Concentrations were as follows: Phenylephrine, 10-6 M;
suramin, 10-5 M; prazosin, 10-6 M; yohimbine, 10-6 M; UK-14304, 10-6 M.  Each value is
expressed as mean ± S.E. from 3 independent preparations.  Values significantly different
from control are indicated by a P ＜ 0.05, b P ＜ 0.01.  Values significantly different from
PDGF alone are indicated by c P ＜ 0.05, d P ＜ 0.01. 
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Table 2.  Effects of U-73122, sphingosine, PMA and ionomycin on PDGF-stimulated
hepatocyte DNA synthesis and poliferation 
Treatment          DNA synthesis       Number of nuclei 
(dpm/mg protein/h x 10-3)       (% of control) 
           Culture time (hr)      Culture time (hr)  
      4      21      4      21 
Control 0.475±0.211 0.596±0.448 100.0±2.4 99.9±3.7 
PDGF 5.364±0.833b 2.969±0.599a 121.1±3.3b 126.6±3.9b 
+phenylephrine  10.211±0.951b, c 3.725±0.835a 140.3±4.1b, c 141.0±3.2b, c 
+U-73122          1.463±0.533c 5.896±1.004b 100.3±3.8c 126.7±3.7b 
+U-73343          5.167±0.634b 2.972±1.065 121.9±4.2a 127.3±4.2b 
+sphingosine         1.755±0.560c 6.338±0.673b, c 105.9±3.4c 132.9±4.9b 
+ionomycin  7.034±0.745b 3.021±0.822 123.3±3.5b 124.0±3.4b 
+PMA  12.063±0.934b, d 3.281±0.633a 145.3±4.2b, c 145.7±4.5b, c 
+PMA+U-73122  12.061±1.003b, d 3.833±1.011a 144.6±4.0b, c 146.0±4.6b, c 
+PMA+U-73343  12.003±0.905b, d 3.685±0.621a 145.6±4.7b, c 145.8±4.8b, c 
+PMA+sphingosine  6.273±1.301a 4.288±1.102a 130.6±2.0b 139.0±4.0b 
+PMA+ionomycin  12.236±1.023b, d 3.056±0.879 144.3±4.4b, c 144.6±4.0b, c 
 
Hepatocytes were plated at a density of 3.3 x 104 cells/cm2 and cultured as described in legend
for Fig. 1.  U-73122, U-73343, sphingosine, ionomycin, phenylephrine and PMA were added
with 10 ng /ml PDGF immediately after medium change and cells were cultured for a further 4
hr and 21 hr.  Concentrarions were as follows: Phenylephrine, 10-6 M; U-73122, 3 x 10-6 M;
U-73343, 10-5 M; sphingosine, 10-5 M; ionomycin, 10-5 M; PMA, 10-7 M.  Each value is expressed
as mean ± S.E. from 3 independent preparations.  Values significantly different from control
are indicated by a P ＜ 0.05, b P ＜ 0.01. Values significantly different from PDGF alone are
indicated by c P ＜ 0.05, d P ＜ 0.01.  
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Table 3.  Effect of specific inhibitors of signal-transducing elements on hepatocyte DNA
synthesis and number of nuclei induced by phenylephrine in the presence of PDGF 
Treatment                            DNA synthesis              Number of nuclei 
(dpm/mg protein/h x 10-3)           (% of control) 
                                   Culture time (hr)             Culture time (hr)     
       4      21      4      21 
Control 0.683±0.459 0.629±0.391 100.0±3.0 100.3±4.1 
PDGF 5.024±0.780b, 2.939±0.690 119.7±3.5a 125.2±3.0b 
+phenylephrine  10.226±1.074b, c 3.434±1.056 139.4±3.4b, c 140.2±4.2b, c
+genistein       0.821±0.431d 0.779±0.630  101.3±4.1c 103.0±3.6d 
+phenylephrine+genistein 0.972±0.506c 0.877±0.401 102.5±3.6c 104.7±4.7c 
+wortmannin   0.742±0.567c 0.693±0.573 102.2±4.5c 101.3±5.0c 
+phenylephrine+wortmannin  0.750±0.538c 0.622±0.607 103.2±3.5c 102.3±4.0c 
+rapamycin        0.709±0.394d 0.579±0.448c 100.3±3.1c 99.7±3.7d 
+phenylephrine +rapamycin 0.732±0.323d 0.497±0.324c 100.8±3.1c 100.2±3.1d 
 
Hepatocytes were plated at a density of 3.3 x 104 cells/cm2 and cultured as described in legend
for Fig. 1.  Specific inhibitors of signal-transducing elements were added with 10 ng/ml PDGF
immediately after medium change and cells were cultured for a further 4 hr and 21 hr.
Concentrations were as follows: Phenylephrine, 10-6 M; genistein, 5 x 10-6 M; wortmannin, 10-7
M; rapamycin, 10 ng/ml.  Each value is expressed as mean ± S.E. from 3 independent
preparations.  Values significantly different from control are indicated by a P ＜ 0.05, b P ＜
0.01.  Values significantly different from PDGF alone are indicated by c P ＜ 0.05, d P ＜ 0.01.
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